HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glutathione-doxorubicin conjugate

Also Known As:

GSH-DXR conjugate

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Asakura, T: 2 articles (10/2001 - 09/2001)
2.	Ohkawa, K: 2 articles (10/2001 - 09/2001)
3.	Tashiro, K: 2 articles (10/2001 - 09/2001)
4.	Aoki, Katsuhiko: 1 article (01/2010)
5.	Asakura, Tadashi: 1 article (01/2010)
6.	Matsudaira, Hiroshi: 1 article (01/2010)
7.	Matsuura, Tomokazu: 1 article (01/2010)
8.	Nakajima, Hisato: 1 article (01/2010)
9.	Ohkawa, Kiyoshi: 1 article (01/2010)
10.	Searashi, Yasuyuki: 1 article (01/2010)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 10/15/2001 - "Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells." 01/01/1997 - "Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells."
2.	Neoplasms (Cancer) 09/01/2001 - "We have reported that glutathione-doxorubicin conjugate (GSH-DXR) exhibited potent cytotoxicity against tumor cells and inhibited glutathione-S-transferase (GST) enzyme activity. "
3.	Carcinoma (Carcinomatosis) 01/01/2010 - "Target chemotherapy of anti-CD147 antibody-labeled liposome encapsulated GSH-DXR conjugate on CD147 highly expressed carcinoma cells."

Related Drugs and Biologics

1.	Glutathione Transferase (Glutathione S-Transferase)
2.	Liposomes (Liposome)
3.	Enzymes
4.	Doxorubicin (Adriamycin)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)